Advertisement
Journal Home
Search for

Volume 176, Issue 1, Pages 27-35 (September 2004)


View previous. 20 of 32 View next.

Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (−/−) mice

Kuang-Yuh Chyua, Odette S Reyesa, Xiaoning Zhaoa, Juliana Yanoa, Paul Dimayugaa, Jan Nilssonb, Bojan Cerceka, Prediman K ShahaCorresponding Author Informationemail address

Received 14 May 2003; received in revised form 25 December 2003; accepted 8 April 2004.

Abstract 

Background: Immunization of animals with LDL reduces atherosclerosis. However, whether the timing of immunization affects its efficacy is not known. In this study, we evaluated the influence of timing of immunization on the athero-protective effects of LDL immunization in apo E (−/−) mice. Methods and results: Hypercholesterolemic apo E (−/−) mice were immunized with native LDL (nLDL) at age of 6–7 weeks old or at 20 weeks old. Compared to adjuvant group, mice that were immunized at the age of 6–7 weeks developed significantly smaller aortic sinus plaques with reduced gelatinolytic activity and increased collagen content. This was associated with an increase of oxidized LDL (oxLDL) antibody titer and a marked decrease in splenic IL-4 mRNA expression. Immunization at 20 weeks of age also increased oxLDL antibody titer but did not reduce plaque size, gelatinolytic activity or collagen content but resulted in a modest decrease in macrophage infiltration. Late immunization did not alter splenic IL-4 mRNA expression. Conclusions: Our findings demonstrate that, only early nLDL immunization modulates humoral and cellular immune responses and affects plaques size and composition in apo E (−/−) mice, indicating the critical importance of timing of immunization for its antiatherogenic efficacy.

a Atherosclerosis Research Center, Division of Cardiology, Department of Medicine and Burns and Allen Research Institute, Cedars-Sinai Medical Center and UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, CA 90048, USA

b Department of Medicine, Lund University, University Hospital MAS, Malmo, Sweden

Corresponding Author InformationCorresponding author. Present address: Room 5347, 8700 Beverly Blvd, Los Angeles, CA 90048, USA. Tel.: +1 310 423 3884; fax: +1 310 423 0144.

PII: S0021-9150(04)00232-1

doi:10.1016/j.atherosclerosis.2004.04.016


View previous. 20 of 32 View next.

Advertisement